Position in NBIX
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$479,664
+$37,150 QoQ
Shares Held
2,846
-15.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#482
of 768 holders
Holding Since
Jun 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Perpetual Ltd holds $861,112 across 2 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (55.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
This page
|
2,846 | $479,664 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
704 | $381,448 |
All Filings in NBIX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $479,664 | 2,846 | Shares | Defined | 2026-07-15 | |
| 2026-03-31 | $442,514 | 3,359 | Shares | Defined | 2026-04-14 | |
| 2025-12-31 | $388,472 | 2,739 | Shares | Defined | 2026-01-20 | |
| 2025-06-30 | $368,271 | 2,930 | Shares | Defined | 2025-07-11 | |
| 2025-03-31 | $324,058 | 2,930 | Shares | Defined | 2025-04-24 | |
| 2024-12-31 | $1,788,286 | 13,101 | Shares | Defined | 2025-01-17 | |
| 2024-09-30 | $1,447,163 | 12,560 | Shares | Defined | 2024-10-09 | |
| 2024-06-30 | $879,711 | 6,390 | Shares | Defined | 2024-07-30 | |
| 2024-03-31 | $937,855 | 6,800 | Shares | Defined | 2024-04-16 | |
| 2023-12-31 | $894,123 | 6,786 | Shares | Defined | 2024-02-15 | |
| 2023-06-30 | $213,872 | 2,268 | Shares | Defined | 2023-07-13 | |
| No filing history on record for this holder in this stock. | ||||||